Latest Breaking News On - Reference listed drug - Page 10 : comparemela.com

Strides Pharma hits fresh 52-week high after tentative US FDA nod for Dolutegravir tablets

The stocks of the company were trading over 9.50 per cent higher at Rs 513 per share, as of 11:23 am, on BSE.

United statesBarun kumarUnited states food drug administrationStrides pharma global pteTivicay tablets of viiv healthcare companyStrides pharmaStrides pharma global pte limitedUnited states foodDrug administrationReference listed drugTivicay tabletsViiv healthcareManaging directorExecutive chairpersonStrides pharma stocksIndian stock market

Strides Pharma Science Singapore arm secures USFDA tentative okay for HIV drug Dolutegravir

This medication is the first line of antiretroval therapy for treatment naïve patients.

New yorkUnited statesTamil naduStrides pharma scienceUnited states food drug administrationTivicay tablets of viiv healthcare companyStrides pharma science limitedStrides pharma globalUnited states foodDrug administrationReference listed drugViiv healthcareChestnut ridgeStrides pharma newsDolutegravir tabletsTivicay tablets

Strides receives tentative USFDA approval for Dolutegravir tablets

Strides receives tentative USFDA approval for Dolutegravir tablets
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Tivicay tablets of viiv healthcare companyStrides pharma scienceStrides pharma science limitedUnited states food drug administrationPharma science limitedStrides pharma globalUnited states foodDrug administrationReference listed drugTivicay tabletsViiv healthcareChestnut ridge

ANI Pharma (ANIP) Announces FDA Approval and Launch of Estradiol Tablets USP

ANI Pharma (ANIP) Announces FDA Approval and Launch of Estradiol Tablets USP
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLisam wilsonNikhil lalwaniSite communications incCompany nasdaqExchange commissionAni pharmaceuticals incPharmaceuticals incDrug administrationAbbreviated new drug applicationEstradiol tabletsReference listed drugEstradiol gelChief executive officerRare diseaseNorth american

ANI Pharmaceuticals Announces the FDA Approval and Launch

BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S..

United statesLisam wilsonNikhil lalwaniCompany nasdaqSite communications incDrug administrationPharmaceuticals incExchange commissionAbbreviated new drug applicationEstradiol tabletsReference listed drugEstradiol gelChief executive officerRare diseaseNorth americanPrivate securities litigation reform act